Condensed Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020		49,156,753
Beginning balance (in shares) at Dec. 31, 2020			0
Beginning balance at Dec. 31, 2020	$ (31,067)	$ 5	$ 0	$ 434,917	$ 0	$ (465,989)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	(27,907)					(27,907)
Share-based payments (in shares)		62,630
Share-based payments	597			597
Warrants liability	(10,290)			(10,290)
Ending balance (in shares) at Mar. 31, 2021		49,219,383
Ending balance (in shares) at Mar. 31, 2021			0
Ending balance at Mar. 31, 2021	(68,667)	$ 5	$ 0	425,224	0	(493,896)
Beginning balance (in shares) at Dec. 31, 2020		49,156,753
Beginning balance (in shares) at Dec. 31, 2020			0
Beginning balance at Dec. 31, 2020	(31,067)	$ 5	$ 0	434,917	0	(465,989)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	(177,788)
Other comprehensive loss	0
Ending balance (in shares) at Sep. 30, 2021		247,305,663
Ending balance (in shares) at Sep. 30, 2021			(316,446)
Ending balance at Sep. 30, 2021	857,495	$ 25	$ (3,007)	1,504,254	0	(643,777)
Beginning balance (in shares) at Mar. 31, 2021		49,219,383
Beginning balance (in shares) at Mar. 31, 2021			0
Beginning balance at Mar. 31, 2021	(68,667)	$ 5	$ 0	425,224	0	(493,896)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	(129,356)					(129,356)
Share-based payments (in shares)		1,118,846	235,856
Share-based payments	7,362		$ (2,256)	9,618
Shares issued in business combination (in shares)		196,700,000
Shares issued in business combination	1,064,549	$ 20		1,064,529
Ending balance (in shares) at Jun. 30, 2021		247,038,229
Ending balance (in shares) at Jun. 30, 2021			(235,856)
Ending balance at Jun. 30, 2021	873,888	$ 25	$ (2,256)	1,499,371	0	(623,252)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	(20,525)					(20,525)
Other comprehensive loss	0
Share-based payments (in shares)		267,434	80,590
Share-based payments	4,132		$ (751)	4,883
Ending balance (in shares) at Sep. 30, 2021		247,305,663
Ending balance (in shares) at Sep. 30, 2021			(316,446)
Ending balance at Sep. 30, 2021	$ 857,495	$ 25	$ (3,007)	1,504,254	0	(643,777)
Beginning balance (in shares) at Dec. 31, 2021	247,358,412	247,358,412
Beginning balance (in shares) at Dec. 31, 2021	(318,086)		(318,086)
Beginning balance at Dec. 31, 2021	$ 858,510	$ 25	$ (3,020)	1,508,995	0	(647,490)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	(3,273)					(3,273)
Share-based payments (in shares)		102,630	21,505
Share-based payments	3,272		$ (287)	3,559
Ending balance (in shares) at Mar. 31, 2022		247,461,042
Ending balance (in shares) at Mar. 31, 2022			(339,591)
Ending balance at Mar. 31, 2022	$ 858,509	$ 25	$ (3,307)	1,512,554	0	(650,763)
Beginning balance (in shares) at Dec. 31, 2021	247,358,412	247,358,412
Beginning balance (in shares) at Dec. 31, 2021	(318,086)		(318,086)
Beginning balance at Dec. 31, 2021	$ 858,510	$ 25	$ (3,020)	1,508,995	0	(647,490)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	7,968
Other comprehensive loss	$ (10,287)
Ending balance (in shares) at Sep. 30, 2022	248,069,853	248,069,853
Ending balance (in shares) at Sep. 30, 2022	(878,837)		(878,837)
Ending balance at Sep. 30, 2022	$ 862,030	$ 25	$ (6,903)	1,518,717	(10,287)	(639,522)
Beginning balance (in shares) at Mar. 31, 2022		247,461,042
Beginning balance (in shares) at Mar. 31, 2022			(339,591)
Beginning balance at Mar. 31, 2022	858,509	$ 25	$ (3,307)	1,512,554	0	(650,763)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	13,623					13,623
Other comprehensive loss	(2,636)				(2,636)
Share-based payments (in shares)		607,561	150,420
Share-based payments	629		$ (1,156)	1,785
Ending balance (in shares) at Jun. 30, 2022		248,068,603
Ending balance (in shares) at Jun. 30, 2022			(490,011)
Ending balance at Jun. 30, 2022	870,125	$ 25	$ (4,463)	1,514,339	(2,636)	(637,140)
Increase (Decrease) in Stockholders' Deficit [Roll Forward]
Net income (loss)	(2,382)					(2,382)
Other comprehensive loss	(7,651)				(7,651)
Common stock repurchases (in shares)			(388,521)
Common stock repurchases	(2,437)		$ (2,437)
Share-based payments (in shares)		1,250	305
Share-based payments	$ 4,375		$ (3)	4,378
Ending balance (in shares) at Sep. 30, 2022	248,069,853	248,069,853
Ending balance (in shares) at Sep. 30, 2022	(878,837)		(878,837)
Ending balance at Sep. 30, 2022	$ 862,030	$ 25	$ (6,903)	$ 1,518,717	$ (10,287)	$ (639,522)